This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tokyo University of Science Foundation. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Takuya Nojima: Innovator in B Cell Research
Introduction
Takuya Nojima is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of immunology, particularly in the production of antigen-specific B cell populations. His innovative work has implications for therapeutic applications in various diseases.
Latest Patents
Takuya Nojima holds a patent titled "Methods of producing antigen-specific B cell populations in the presence of CD40:CD40L, BAFF:BAFF receptor and Fas:FasL stimulation." This patent describes a method for producing an antigen-specific B cell population that includes IgG-positive B cells specific to a particular antigen. The method involves culturing IgG-positive B cells with the specific antigen in the presence of IL-21, while providing stimulation through CD40, a BAFF receptor, and Fas. The process includes screening for antigen-specific B cells to obtain a population comprising these IgG-positive B cells. He has 1 patent to his name.
Career Highlights
Takuya Nojima is affiliated with the Tokyo University of Science Educational Foundation Administrative Organization. His work at this institution has allowed him to explore advanced methodologies in B cell research, contributing to the scientific community's understanding of immune responses.
Collaborations
One of his notable collaborators is Daisuke Kitamura. Their partnership has fostered advancements in the field, enhancing the research output and innovation in B cell studies.
Conclusion
Takuya Nojima's contributions to immunology through his patent and research at the Tokyo University of Science Educational Foundation Administrative Organization highlight his role as an influential inventor in the scientific community. His work continues to pave the way for future advancements in therapeutic applications.